WNT1 and cancer: Taken together the decreased TCR stimulation, low granzyme B secretion and impaired cytotoxicity of in vitro and in vivo primed T cells by intratumoral Wnt1-cDCs, these data collectively show that Wnt1 suppresses the ability of cDCs to cross-prime T cytotoxic cells against cancer-specific antigens.